CaliPharms, Inc.
KGET
$0.00
$0.000.00%
| 09/30/2014 | 06/30/2014 | 03/31/2014 | 09/30/2013 | ||
|---|---|---|---|---|---|
| Revenue | 60.00K | 33.00K | 19.60K | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 60.00K | 33.00K | 19.60K | -- | |
| Cost of Revenue | 67.40K | 50.80K | 24.80K | -- | |
| Gross Profit | -7.40K | -17.90K | -5.30K | -- | |
| SG&A Expenses | 224.10K | 162.00K | 328.90K | 184.50K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 291.50K | 212.80K | 353.80K | 184.50K | |
| Operating Income | -231.60K | -179.90K | -334.20K | -184.50K | |
| Income Before Tax | -4.18M | -1.31M | -784.00K | -185.00K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -4.18M | -1.31M | -784.00K | -185.00K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -4.18M | -1.31M | -784.00K | -185.00K | |
| EBIT | -231.60K | -179.90K | -334.20K | -184.50K | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 0.00 | 0.00 | 0.00 | -- | |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -- | |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -- | |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -- | |
| Average Basic Shares Outstanding | 3.36B | 3.08B | 3.05B | -- | |
| Average Diluted Shares Outstanding | 3.36B | 3.08B | 3.05B | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
